› Forums › General Melanoma Community › NKTR-214 drug company has manufacturing issue!!!
- This topic has 2 replies, 2 voices, and was last updated 6 years, 5 months ago by
MelanomaMike.
- Post
-
- August 11, 2019 at 3:27 pm
Last week I posted that NKTR-214 + Nivo drug trial was given FDA fast track approval, only to have the company announce this last Thursday that some of their patients got “suboptimal” drug in two batches. This is just crazy shit, I can’t imagine being in the trial and finding out that you got “suboptimal” drug. I came across these two links on the twitter feed from Dr. Jason Luke who shared the news on Aug 8th to his followers. https://www.investors.com/news/technology/nektar-stock-halted-biotech-company-sales-lag-expectations/ https://twitter.com/jasonlukemd
Viewing 1 reply thread
- Replies
-
-
- August 12, 2019 at 5:00 pm
Well thats a huge “Ooops”!..
Viewing 1 reply thread
- You must be logged in to reply to this topic.